![David M. Konys](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. David M.
Konys is Vice President-Manufacturing Operations at Alnylam Pharmaceuticals, Inc.
Mr. Konys was previously employed as President & Managing Director by Biogen Idec Canada, Inc. and Vice President-Corporate Development by Ingenium Pharmaceuticals GmbH.
| Sociétés | Poste | Fin |
|---|---|---|
Biogen Canada, Inc.
 Biogen Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Biogen, Inc., Biogen Canada, Inc. is a biotechnology company that develops therapies for complex and devastating diseases, focusing on neurology, neuropsychiatry, specialized immunology, and rare diseases. The company is based in Mississauga, Canada. The Canadian company has created medicines for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer ’ s disease, and supports clinical trials, early access programs, and safe medicine manufacturing. | President | - |
Ingenium Pharmaceuticals GmbH
 Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutic drugs | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutic drugs | Commercial Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Biogen Canada, Inc.
Biogen Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Biogen, Inc., Biogen Canada, Inc. is a biotechnology company that develops therapies for complex and devastating diseases, focusing on neurology, neuropsychiatry, specialized immunology, and rare diseases. The company is based in Mississauga, Canada. The Canadian company has created medicines for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer ’ s disease, and supports clinical trials, early access programs, and safe medicine manufacturing. | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
